MB PHARMA s.r.o.

MB PHARMA s.r.o. focuses on clinical research in complicated skin wounds, including wounds that heal by secondary intention and remain infected during recovery. The sponsor’s studies address both acute and chronic wound settings where granulation tissue formation and local infection control are central therapeutic concerns.

• Infected surgical wounds
• Traumatic wound complications
• Chronic wound management

The clinical interest extends to restoring wound closure while managing persistent microbial burden in lesions that are slow to heal.